Jason A. Incorvati Joins Department of Hematology/Oncology at New Fox Chase Cancer Center East Norriton Campus

Jason A. Incorvati, MD
Jason A. Incorvati, MD

PHILADELPHIA (December 14, 2017) – Fox Chase Cancer Center is pleased to announce the hiring of Jason A. Incorvati, MD, who will join the Department of Hematology/Oncology as an assistant professor, and will treat patients at the new Fox Chase Cancer Center East Norriton Hospital Outpatient Center. Along with his duties at the East Norriton site, he will see breast cancer patients at the main Fox Chase campus.

Incorvati earned his medical degree from Temple University School of Medicine before completing his residency in internal medicine at the University of Maryland and fellowship in hematology/oncology at the State University of New York at Stony Brook. He is Board Certified in internal medicine, medical oncology, and hematology, and also brings a robust research background, including involvement in several clinical trials.

“We’re excited for Dr. Incorvati to join our team at Fox Chase,” said Martin Edelman, MD, chair of the Department of Hematology/Oncology. “He brings extensive real world clinical experience coupled with a strong interest in clinical research. I am confident he will be a great fit for our team and a fantastic asset at our new East Norriton campus.”

The Fox Chase Cancer Center East Norriton Hospital Outpatient Center is anticipated to open in early 2018 and will offer access to Fox Chase’s multidisciplinary care by surgical oncologists, hematologists/oncologists, radiation oncologists, and support staff including onsite radiation and infusion treatments. Patients will also have access to Fox Chase Cancer Center’s unique support services, including nurse navigation, and the option to enroll in clinical trials.

Incorvati will begin his new role at Fox Chase on January 1st, 2018.

Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence six consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.

For more information, call 888-369-2427

Resize Text